Molecule gene analysis of bone absorption in bone reproduction medical care and development of bone absorption restraint medicine
骨再生医疗中骨吸收的分子基因分析及骨吸收抑制药物的开发
基本信息
- 批准号:15390614
- 负责人:
- 金额:$ 9.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Intramuscular injection (1 mg/kg) did immunity restraint agent FK506 to a nude mouse and a mouse of a wild type that a T cell suffered a loss day after day on 28th and made an osteoporosis model mouse to search a cell pro-immunity and relevance with the onset of osteoporosis by immunity restraint agent. As a result, as for the bone absorption of a group of experiments by FK506, decrease of trabecula bone was recognized by a wild type more underneath than enchondral ossification, and, as for positive osteoclast, numbers increased in enchondral ossification for TRAP dyeing more clearly than a group of control again. However, as for the bone absorption in the lower part, as for the osteoporosis by immunity restraint agent, what an immunity system cell such as a T cell was related to was suggested without most than enchondral ossification with a nude mouse by there not being control and a change.I discovered that osteoporosis recovered when we administered Propion acid bacteria fermentatio … More n product (PC) that was a starter of Swiss cheese to this osteoporosis model. We examined a bone absorption restraint effect from this fermentation product this time. I was able to prevent the bone absorption when I administered Propion acid bacteria fermentation product (PC) to an osteoporosis mouse by FK506.In late years a lot of existing DHNA has a naphthoquinone frame the same as vitamins K2 attracting attention in a quantity of bone salt thing having quantity of bone improvement action within a PC.I paid attention to this point, and we accepted bone absorption restraint same as a PC for an osteoporosis model when we administered DHNA alone. As for DHNA, the bone absorption restraint effect of a PC was able to identify a thing by DHNA from what was included in a PC abundantly.I compared osteoclast with control when I added the B cell which was a T cell and the B220 positive that were four twist CD positive in marrow in osteoclast of a mouse namely in vitro of bone bud cell-like strike Rome cell and marrow cell with magnetic beads and increased significantly. Less
28日肌肉注射免疫抑制剂FK506(1 mg/kg)对裸鼠和T细胞连续丢失的野生型小鼠进行免疫抑制,并用免疫抑制剂对骨质疏松模型小鼠进行细胞前免疫及与骨质疏松发病的相关性研究。结果表明,对于FK506实验的一组骨吸收,小梁骨的减少比软骨下骨化更能被野生型识别,而对于破骨细胞阳性,TRAP染色的软骨骨化组又比对照组更明显地增加了数量。然而,对于下部的骨吸收,对于免疫抑制剂引起的骨质疏松症,在没有对照和改变的情况下,建议与免疫系统的T细胞等免疫系统细胞有关,而不是通过裸鼠的软骨成骨。我发现当我们使用丙酸细菌发酵…时,骨质疏松症已经恢复更多的n产品(PC)是这个骨质疏松模型的瑞士奶酪的起始物。我们这次检测了这种发酵产品对骨吸收的抑制作用。我用FK506给骨质疏松小鼠注射丙酸菌发酵产物(PC)时,能够阻止骨吸收。近年来,许多现有的DHNA在PC内有大量具有骨改善作用的骨盐物质,具有与维生素K2相同的萘醌骨架,引起了人们的注意。我注意到了这一点,我们对骨质疏松模型采用了与PC相同的骨吸收抑制。对于DHNA,PC的骨吸收抑制作用能够充分从PC中包含的东西中识别出DHNA所包含的东西。我将破骨细胞与对照组进行比较,当我在小鼠破骨细胞中加入骨髓中四股CD阳性的B细胞(T细胞)和B220阳性细胞,即体外培养的骨芽细胞样撞击罗马细胞和带有磁珠的骨髓细胞时,破骨细胞明显增加。较少
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Vascular Endothelial Growth Factor(VEGF) and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum
血管内皮生长因子(VEGF)和骨形态发生蛋白-4(BMP-4)在移植骨膜软骨内骨化中的作用
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Toshio Sugahara;Takaaki Ueno et al.
- 通讯作者:Takaaki Ueno et al.
骨粗鬆癌学-基礎・臨床研究の新しいパラダイム 免疫抑制剤が引き起こす骨粗鬆症
骨质疏松症肿瘤学 - 基础和临床研究的新范式 免疫抑制剂引起的骨质疏松症
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:菅原利夫;福永城司
- 通讯作者:福永城司
Toshio Sugahara, Takaaki Ueno et al.: "Vascular Endothelial Growth Factor(VEGF)and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum"Acta Histochemistry Cytochemistry. 36(1). 61-66 (2003)
Toshio Sugahara、Takaaki Ueno 等人:“血管内皮生长因子 (VEGF) 和骨形态发生蛋白 4 (BMP-4) 在移植骨膜内软骨骨化中的作用”组织化学细胞化学学报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Vascular Endothelial Growth Factor (VEGF) and Bone Morphogenetic Protein-4 (BMP-4) in Endochondra Ossification from Grafted Periosteum
血管内皮生长因子 (VEGF) 和骨形态发生蛋白 4 (BMP-4) 在移植骨膜软骨内骨化中的作用
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Toshio Sugahara;Takaaki Ueno et al.
- 通讯作者:Takaaki Ueno et al.
Toshio Sugahara, Takaaki Ueno et al.: "Pathological change of articular cartilage in the mandibular head treated with immunosuppressant FK506"Histology and Histopathology. 19. 15-21 (2004)
Toshio Sugahara、Takaaki Ueno 等:“免疫抑制剂 FK506 治疗下颌骨头关节软骨的病理变化”组织学和组织病理学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGAHARA Toshio其他文献
SUGAHARA Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGAHARA Toshio', 18)}}的其他基金
Research on metabolic mechanism of palatal processes and cleft palate onset mechanism from genes
从基因角度研究腭突代谢机制及腭裂发病机制
- 批准号:
16K11772 - 财政年份:2016
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Localization of Perlecan and Heparanase in the Epithelial
基底膜聚糖和乙酰肝素酶在上皮细胞中的定位
- 批准号:
22592269 - 财政年份:2010
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular and genetic analysis of osteoclast differentiantion factor and osteoclastgenesis inhibitory factor in osteoporosis and control of inhibition of bone resorption by 1, 4-dihydroxy-2-naphthoic acid(DHNA)
破骨细胞分化因子和破骨细胞生成抑制因子在骨质疏松症中的分子和遗传学分析及1, 4-二羟基-2-萘甲酸(DHNA)抑制骨吸收的控制
- 批准号:
19390516 - 财政年份:2007
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study of molecular and gene analysis and bone metabolism-improving effect of propiomibacterium freudenreichii milk whey culture against osteoporosis.
费氏丙酸杆菌乳清培养物抗骨质疏松的分子基因分析及骨代谢改善作用研究
- 批准号:
17390538 - 财政年份:2005
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A design and manufacture using CAD and CAE system, and its clinical application
利用CAD和CAE系统设计制造及其临床应用
- 批准号:
13470435 - 财政年份:2001
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical application of our developed artificial temporomandibular joint. 1)study on respiratory function, especially sleep apnea syndrome, 2)study on jaw movement
我们研制的人工颞下颌关节的临床应用。
- 批准号:
10470433 - 财政年份:1998
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
THE STUDY OF A JAW MOVEMENT BEFORE AND AFTER TOTAL TMJ REPLACEMENT
全颞下颌关节置换术前后下颌运动的研究
- 批准号:
08457548 - 财政年份:1996
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a simulator for educational oral surgery using virtual reality
使用虚拟现实开发口腔外科教育模拟器
- 批准号:
08557115 - 财政年份:1996
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of artificial tempolomandibular joint
人工颞下颌关节的研制
- 批准号:
05557090 - 财政年份:1993
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Investigation into Pre and Post Operative Functional Changes of Jaw Movement and Oral Cavity Related Muscles of Maxillofacial Deformaties.
颌面畸形下颌运动和口腔相关肌肉手术前后功能变化的调查。
- 批准号:
04454501 - 财政年份:1992
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
- 批准号:81601942
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
一个潜在的、防治骨质破坏的药物靶点的新发现
- 批准号:30670997
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
- 批准号:
10648513 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:
23K16044 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Osteoclast fusion and regulation by DC-STAMP and OC-STAMP
DC-STAMP 和 OC-STAMP 的破骨细胞融合和调节
- 批准号:
23K16132 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Osteoclast programming and reprogramming during osteoclastogenesis
破骨细胞生成过程中的破骨细胞编程和重编程
- 批准号:
10776112 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Elucidation of the pathogenesis of glucocorticoid-induced osteoporosis targeting newly identified circulating osteoclast precursor cells
针对新发现的循环破骨细胞前体细胞阐明糖皮质激素诱导的骨质疏松症的发病机制
- 批准号:
23K08707 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of osteoclast endocrine and paracrine communications by systems genetics approaches
通过系统遗传学方法鉴定破骨细胞内分泌和旁分泌通讯
- 批准号:
10716388 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Regulation of Osteoclastogenesis and Inflammatory Osteolysis
破骨细胞生成和炎性骨质溶解的调节
- 批准号:
10681786 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
CKD-MBDにおけるOsteoclast-associated receptor (OSCAR)の役割の検討
检查破骨细胞相关受体 (OSCAR) 在 CKD-MBD 中的作用
- 批准号:
23K15233 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gene Regulatory Nework Analysis within lving single cell including osteoclast
包括破骨细胞在内的活单细胞内的基因调控网络分析
- 批准号:
23K15736 - 财政年份:2023
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists